Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Hoffmann-La Roche
  • # Alzheimer's
  • # DNA
  • # Diabetes
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Clinical Trials Observed Cardiovascular Death and Worsening Heart Failure Reduced by Finerenone

4 September 2024

Combination of chemotherapy and dual-targeted treatments Phase III Breakwater Clinical trials supported for BRAF-mutated metastatic colorectal cancer FDA approval

26 January 2025

U.S. FDA Approved GSK’s Blujepa (gepotidacin) for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) for Female Adults and Paediatric Patients 12 years of Age and Older

25 March 2025

New approaches in the fight against drug resistance in malaria

21 November 2023

Single Cell Atlas; a pioneer for biomedical research

29 April 2024

A New Study Reveals the Secret to a Sustained Immune Response in Cancer and Chronic Illnesses

3 February 2025

Amgen Announces $900 Million Worth Expansion of Manufacturing Facility in the US

26 April 2025

Light Microscopy Vs Electron Microscopy – Understanding the Differences and Applications

2 April 2023

Moderna succeeds in mRNA flu shot after phase 3 trials; seeking approval

14 September 2023

Scientists discovered infectious H5N1 Influenza Virus in raw milk rapidly declines with heat treatment

17 June 2024

First baby born from DNA of three people in UK

14 May 2023

Diagnosis of prostate cancer made advanced by microscopy plus deep learning

12 March 2024

Business

CellCentric Secures $120 Million Investment to Develop Oral Myeloma Drug Inobrodib
Business Cancer Healthcare & Pharmaceuticals

CellCentric Secures $120 Million Investment to Develop Oral Myeloma Drug Inobrodib

Athulya B S 19 May 2025

CellCentric has secured $120 million in Series C funding to accelerate clinical development of Inobrodib, its first-in-class oral p300/CBP inhibitor for treating multiple myeloma. The investment will support upcoming Phase II/III trials and global expansion.

NKure Therapeutics and CRISPR Therapeutics Partner to Advance CTX112™ for Cancer Treatment in India
Biotechnology Business News

NKure Therapeutics and CRISPR Therapeutics Partner to Advance CTX112™ for Cancer Treatment in India

Editor's Desk 7 May 2025

Compared to existing CAR T treatments, the off-the-shelf experimental therapeutic CTX112TM may allow for quicker patient access.

IQVIA Announces First-Quarter 2025 Financial Results
Business News

IQVIA Announces First-Quarter 2025 Financial Results

Athulya B S 7 May 2025

IQVIA reported $3.829 billion in total revenue for the first quarter that ended on March 31, 2025, a 2.5% increase over the same period in 2024.

Amgen Reports Strong Q1 2025 Results Driven by Robust Volume Growth and Key Product Performance
Business News

Amgen Reports Strong Q1 2025 Results Driven by Robust Volume Growth and Key Product Performance

Ajmal Aseem 5 May 2025

Amgen Inc. (NASDAQ: AMGN) announced its financial results for the first quarter ended March 31, 2025, showcasing significant revenue growth fueled by strong product volume increases across its portfolio. Financial Highlights Total Revenue: Increased 9% year-over-year to $8.1 billion, compared to $7.4 billion in Q1 2024. Product Sales: Grew 11% […]

Moderna Reports Q1 2025 Results: Revenue Dips, Focus Shifts to Oncology Amid Expense Cuts
Business News

Moderna Reports Q1 2025 Results: Revenue Dips, Focus Shifts to Oncology Amid Expense Cuts

Ajmal Aseem 4 May 2025

Moderna, Inc. announced its financial results for the first quarter ending March 31, 2025, highlighting a strategic realignment towards oncology and other pipeline candidates amidst declining revenues compared to the previous year. Financial Highlights Revenue: The company reported total revenue of $108 million for Q1 2025, a decrease from $167 […]

Eli Lilly Reported a Very Strong Start to 2025, Characterized by Significant Revenue Growth
Business News

Eli Lilly Reported a Very Strong Start to 2025, Characterized by Significant Revenue Growth

Athulya B S 1 May 2025

Revenue reached $12.73 billion, a substantial 45% increase year-over-year, primarily fueled by strong volume growth from Mounjaro and Zepbound.

Roche granted FDA breakthrough device designation for VENTANA TROP2, an AI-driven companion diagnostic for non-small cell lung cancer
Business Medical Devices News Regulatory

Roche granted FDA breakthrough device designation for VENTANA TROP2, an AI-driven companion diagnostic for non-small cell lung cancer

Athulya B S 29 April 2025

The gadget analyzes images using artificial intelligence to achieve a degree of diagnosis accuracy that is not achievable with conventional manual grading techniques.

Amgen Announces $900 Million Worth Expansion of Manufacturing Facility in the US
Business Healthcare & Pharmaceuticals News

Amgen Announces $900 Million Worth Expansion of Manufacturing Facility in the US

Ajmal Aseem 26 April 2025

Amgen has made about $5 billion in direct capital investments in the US since the Tax Cuts and Jobs Act of 2017 was passed.

Roche to Invest USD 50 Billion in United States for Pharmaceuticals and Diagnostics Over the Next Five Years
Business Healthcare & Pharmaceuticals News

Roche to Invest USD 50 Billion in United States for Pharmaceuticals and Diagnostics Over the Next Five Years

Ajmal Aseem 23 April 2025

More than 12,000 new jobs will be created by investments, including 1,000 at Roche and more than 11,000 to support the development of new manufacturing capabilities in the US.

Pfizer Announces Development Discontinuation of Danuglipron an Oral GLP-1 Receptor Agonist
Business Clinical Investigation Healthcare & Pharmaceuticals News

Pfizer Announces Development Discontinuation of Danuglipron an Oral GLP-1 Receptor Agonist

Ajmal Aseem 14 April 2025

Data from the danuglipron clinical development program will be presented at a scientific meeting or published in a peer-reviewed journal in the future.

Posts pagination

1 2 3 Next

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
  • Novo Nordisk Engineering (NNE) is Hiring a Manufacturing Execution System (MES) Analyst in Bengaluru, India
  • Sartorius is Hiring a Process Technology Engineer in Bengaluru, India – May, 2025
  • Cytiva Hiring a Logistics Specialist in Singapore – May 2025
  • AstraZeneca is Hiring an AI Engineer – Lead Consultant in Chennai, India – May 2025
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy